Clinical Trial Detail

NCT ID NCT04310592
Title Natural Killer Cell (CYNK-001) Infusions in Adults With AML (CYNK001AML01)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Celularity Incorporated
Indications

acute myeloid leukemia

Therapies

Cyclophosphamide + Fludarabine

CYNK-001

Age Groups: senior adult

No variant requirements are available.